Figure 8From: Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodents Antineuropathic effect of chronic oral administration of 30 or 300 mg/kg of 7-hydroxy-3,4-dihydrocadalin (7-DHC), on Monday, Wednesday and Friday for 6 weeks, on 200 mg/kg streptozotocin-induced hyperalgesia and allodynia in diabetic mice. Data are presented as mean ± E.E.M. for 6 animals. *Significantly different (P < 0.05) from control group (diabetic), as was determined by two-way ANOVA followed by Bonferroni’s test.Back to article page